HBsAg and HBV DNA levels guiding entecavir cessation in HBeAg-negative chronic hepatitis B

被引：0
|
作者：
Seto, Wai-Kay
Hui, Aric Josun
Wong, Vincent Wai-Sun
Wong, Grace Lai-Hung
Liu, Kevin
Lai, Ching-Lung
Yuen, Man-Fung
Chan, Henry Lik-Yuen
机构：
[1] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[2] Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
hepatitis B; nucleoside analogue; treatment cessation; HBsAg;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：414 / 414
页数：1
相关论文
共 50 条
  • [31] Low serum HBsAg and HBV DNA levels identify strongest responders of pegylated interferon addition to entecavir in HBeAg positive chronic hepatitis B
    Liem, K. S.
    Hansen, B. E.
    Xie, Q.
    Chen, L.
    Brouwer, W. P.
    Chi, H.
    Guo, S.
    Qi, X.
    Zhang, N. P.
    Tabak, F.
    vanCampenhout, M. J.
    Janssen, H. L.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 27 - 28
  • [32] Comparing Efficacy of Lamivudine, Adefovir Dipivoxil, Telbivudine, and Entecavir in Treating Nucleoside Analogues Nave for HBeAg-Negative Hepatitis B with Medium Hepatitis B Virus (HBV) DNA Levels
    Shi, Hong
    Han, Zongping
    Liu, Jian
    Xue, Jinfang
    Zhang, Shuya
    Zhu, Zhe
    Xia, Jinyu
    Huang, Mingxing
    MEDICAL SCIENCE MONITOR, 2017, 23 : 5230 - 5236
  • [33] Prediction of treatment-related HBsAg loss in HBeAg-negative chronic hepatitis B: a clue from serum HBsAg levels
    Manesis, Emanuel K.
    Hadziyannis, Emilia S.
    Angelopoulou, Olga P.
    Hadziyannis, Stephanos J.
    ANTIVIRAL THERAPY, 2007, 12 (01) : 73 - 82
  • [34] Quantitative HBsAg: Not helpful to evaluate fibrosis in HBeAg-negative chronic hepatitis B patients
    Loureiro, Dimitri
    Mansouri, Abdellah
    Asselah, Tarik
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2019, 25 (05): : 269 - 271
  • [35] Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase
    Chen, Li
    Shi, Junjie
    Lu, Zhonghua
    Ye, Yun
    Zhou, Xinbei
    Tan, Youwen
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (03) : 310 - 316
  • [36] HBsAg levels under interferon and lamivudine therapy in HBeAg-negative chronic hepatitis B (CHBe-) patients
    Manesis, EK
    Hadziyannis, ES
    Agelopoulou, OP
    Hadziyannis, S
    JOURNAL OF HEPATOLOGY, 2005, 42 : 185 - 185
  • [37] HIGH LEVELS OF INTRAHEPATIC INTEGRATED HBV DNA THAT CORRELATED WITH SERUM QUANTITATIVE HBsAg LEVEL IN HBEAG NEGATIVE CHRONIC HEPATITIS B
    Lau, Daryl
    Kim, Elena
    Bai, Chosha
    King, Wendy
    Cui, Yixiao
    Kleiner, David E.
    Ghany, Marc G.
    Nguyen, Thi Thuy Tu
    Hinerman, Amanda
    Wang, Zhili
    Chung, Raymond T.
    Sterling, Richard K.
    Cloherty, Gavin A.
    Su, Ying-Hsiu
    Guo, Haitao
    HEPATOLOGY, 2022, 76 : S37 - S38
  • [38] HBeAg-negative chronic hepatitis
    Ibragimova, MM
    Krel, PE
    Abdurakhmanov, DT
    TERAPEVTICHESKII ARKHIV, 2004, 76 (02): : 87 - 91
  • [39] SERUM HEPATITIS B SURFACE ANTIGEN (HBSAG) TITERS AND HBV DNA LEVELS IN HEPATITIS B E ANTIGEN (HBEAG)-NEGATIVE CHRONIC HEPATITIS B: AN INTERIM ANALYSIS
    Seto, Wai-Kay
    Lai, Ching-Lung
    Fung, James
    Wong, Danny
    Yuen, Chi Hang J.
    Young, John L.
    Tong, Teresa
    Hung, Ivan F. N.
    Yuen, Man-Fung
    HEPATOLOGY, 2011, 54 : 1077A - 1077A
  • [40] Relationship between HBsAg, HBV DNA, covalently closed circular DNA and fibrosis stage in chronic HBV (HBeAg-negative) patients
    Gabdrakhmanov, I.
    Zhdanov, K.
    Kozlov, K.
    Semenov, A.
    Sukachev, V.
    Gvozdetskiy, J. Ostankova A.
    Zhabrov, S.
    Kudelka, E.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S487 - S487
12345